Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- PMID: 32194981
- PMCID: PMC7078228
- DOI: 10.1038/s41421-020-0156-0
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Keywords: Autophagy; Transcription.
Conflict of interest statement
Conflict of interestThe authors declare that they have no conflict of interest.
Figures
Comment in
-
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):256-257. doi: 10.1093/ehjcvp/pvaa041. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 32347923 Free PMC article. No abstract available.
Similar articles
-
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237. Clin Infect Dis. 2020. PMID: 32150618 Free PMC article.
-
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861965 Free PMC article. Review.
-
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.Clin Toxicol (Phila). 2021 Jan;59(1):12-23. doi: 10.1080/15563650.2020.1817479. Epub 2020 Sep 22. Clin Toxicol (Phila). 2021. PMID: 32960100 Review.
-
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.Int J Antimicrob Agents. 2020 May;55(5):105960. doi: 10.1016/j.ijantimicag.2020.105960. Epub 2020 Apr 3. Int J Antimicrob Agents. 2020. PMID: 32251731 Free PMC article.
-
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.Int J Antimicrob Agents. 2020 Sep;56(3):106119. doi: 10.1016/j.ijantimicag.2020.106119. Epub 2020 Jul 30. Int J Antimicrob Agents. 2020. PMID: 32738306 Free PMC article.
Cited by
-
Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.Int J Antimicrob Agents. 2020 Sep;56(3):106101. doi: 10.1016/j.ijantimicag.2020.106101. Epub 2020 Jul 17. Int J Antimicrob Agents. 2020. PMID: 32687949 Free PMC article. Review.
-
Treatment of COVID 19-Repurposing drugs commonly used in dermatology.Dermatol Ther. 2020 Sep;33(5):e13829. doi: 10.1111/dth.13829. Epub 2020 Jul 16. Dermatol Ther. 2020. PMID: 32542964 Free PMC article. Review.
-
Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.Sci Rep. 2021 Mar 31;11(1):7282. doi: 10.1038/s41598-021-85227-0. Sci Rep. 2021. Retraction in: Sci Rep. 2021 Sep 18;11(1):18983. doi: 10.1038/s41598-021-98683-5 PMID: 33790308 Free PMC article. Retracted. Clinical Trial.
-
Cationic drugs and COVID-19.Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420966078. doi: 10.1177/2058738420966078. Int J Immunopathol Pharmacol. 2020. PMID: 33045858 Free PMC article.
-
Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation.Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008686. doi: 10.1161/CIRCEP.120.008686. Epub 2020 Sep 9. Circ Arrhythm Electrophysiol. 2020. PMID: 32907357 Free PMC article. Clinical Trial.
References
-
- Weniger H. Review of side effects and toxicity of chloroquine. Bull. World Health. 1979;79:906.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
